Studieoverzicht - 2022-04 NABOR

 
Number 2022-04 NABOR
Nickname NABOR
Status Open Date: 01-03-2023
Inclusion closed
Other study number(s) niet WMO
Participating parties/groups IKNL-UT-NIVEL
Full title Effectiveness of persoNalized care After treatment for non-metastasized Breast cancer based On risk of Recurrence, personal needs and risk on (late) health effects: the NABOR study.
Phase and type Other
Age ≥18
Menopausal status Both pre- and postmenopausal
Indication Data registration
Subindication Any HER2, any HR
Target sample size 1040
Actual accrual 372 Date: 01-02-2024
Estimated study completion date
CCMO approval Not applicable Date: Nr:
EudraCT nr.
Trial Register
METC approval Not applicable Date: METC: Nr:
Amendments Date:
KWF-CKS approval Date: Nr:
News item
Website https://www.zonmw.nl/nl/onderzoek-resultaten/doelmatigheidsonderzoek/programmas/project-detail/evaluatieonderzoek-zegg/effectiveness-of-personalized-care-after-treatment-for-non-metastasized-breast-cancer-based-on-risk/
Sponsor IKNL
Principal Investigator(s) Prof. dr. S. Siesling (IKNL, UT), dr. J.C. Korevaar (NIVEL)
Study manager Anneleen Klaassen-Dekker; e-mail: NABOR@iknl.nl
Suzanne Jager, Projectmedewerker BOOG, info@boogstudycenter.nl
Central datamanagement and randomization PROFIEL
Monitoring
Local datamanagement NKR-IKNL
Funding ZEGG
Extra

Design:
Objectives:
Endpoints:
Main eligibility criteria:
Documents (public):

 

 ZORGVERLENERS

Uitlegvideo nacontrole keuzehulp: klik op deze link om de video te bekijken. 

 Nacontrole keuzehulp (voor zorgverleners)

 

 PATIËNTEN

Uitlegvideo nacontrole keuzehulp: klik op deze link om de video te bekijken. 

Nacontrole keuzehulp (voor patienten)

 

Uitlegvideo nazorg keuzehulp: klik op deze link om de video te bekijken.

Nazorg keuzehulp (voor patienten)

 

 

Documents (protected):
In order to see this content you need to be logged on.

Login.

Back